The QualityStocks Daily Stock List
- Thin Film Electronics ASA (TFECF)
- HedgePath Pharmaceuticals, Inc. (HPPI)
- Nemaska Lithium, Inc. (NMKEF)
- Sun Pacific Holding Corp. (SNPW)
- Workhorse Group, Inc. (WKHS)
- AltiGen Communications, Inc. (ATGN)
- Canarc Resource Corp. (CRCUF)
- HCi Viocare (VICA)
- Jerrick Media Holdings, Inc. (JMDA)
- Tofutti Brands, Inc. (TOFB)
- Cell Source, Inc. (CLCS)
- The Alkaline Water Company, Inc. (WTER)
- Gilla, Inc. (GLLA)
- Mikros Systems Corp. (MKRS)
Thin Film Electronics ASA (TFECF)
Speculating Stocks, Dividend Investor, Wallet Investor, Penny Stock Millionaire, Penny Stock Tweets, Stockhouse, TradingView, OTC Markets, InvestorsHub, The Street and 4-Traders reported earlier on Thin Film Electronics ASA (TFECF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Thin Film Electronics ASA provides near field communication (NFC) mobile marketing and smart-packaging solutions by printed electronics technology. It provides end-to-end mobile marketing solutions that feature hardware, label/packaging integration services, and a robust cloud-based software platform.
OTCQX-listed, Thin Film Electronics is based in Oslo, Norway. Additionally, the Company has offices in Silicon Valley, Sweden, San Francisco, London, and Shanghai.
Thin Film’s vision is to make everyday items ‘just smart enough’, thus, effectively extending the traditional boundaries of the IoT to create the Internet of Everything. The Company has 270 patents and patents-pending.
Thin Film’s products include NFC Solutions. NFC involves hardware and software designed with volume production in mind. NFC Solutions is built on highly scalable printed electronics technology. NFC features OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. In addition, it features SpeedTap™ Technology - Single-ID tag.
Moreover, Thin Film’s products include EAS Tags. These are for retailers to strengthen their retail loss-prevention programs with next-generation anti-theft tags. The Company’s 8.2MHz tags are compatible with globally installed infrastructure. Integrated EAS maximizes product availability and minimizes loss. EAS Tags also reduce overhead associated with hard tag application and removal.
This past November, Thin Film announced it received the IDTechEx Technical Development in Manfacturing award in recognition of its pioneering roll-to-roll printed electronics fab in San Jose, California. The IDTechEx Awards were presented as part of the Printed Electronics USA 2018 conference. They recognize company development and success in the field of printed electronics.
The Technical Development in Manufacturing award recognizes the most significant development of a manufacturing device, process, or production plant in the industry over the last 24 months. Award recipients must demonstrate the optimization of a lab-scale or mass-scale production process through improving productivity, quality, reliability, uniformity, or scale.
Thin Film’s San Jose facility features a 22,000 sq-ft printed electronics factory, which is the world’s first production roll-to-roll (R2R) printed electronics line using stainless steel substrates. The design of the fab is for an annual production capacity of up to seven billion units. It is optimized to enable production of low-cost, mechanically strong devices enabling high-volume applications. This includes NFC (near field communication) for mobile marketing, authentication, as well as supply chain services.
Thin Film Electronics ASA (TFECF), closed Monday's trading session at $0.0815, even for the day. The average volume for the last 3 months is 13,225 and the stock's 52-week low/high is $0.0682/$0.308.
HedgePath Pharmaceuticals, Inc. (HPPI)
Simply Wall St, 4-Traders, Infront Analytics, Morningstar, MarketWatch, InvestorsHub, BUYINS.NET, Stockhouse, Dividend Investor, and Wallet Investor reported earlier on HedgePath Pharmaceuticals, Inc. (HPPI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company headquartered in Tampa, Florida. It discovers, develops, and plans to commercialize front-line therapeutics for patients with cancer. The Company is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. HedgePath Pharmaceuticals lists on the OTC Markets Group’s OTCQB.
HedgePath is the exclusive United States licensee of a patented formulation of itraconazole, called SUBA-Itraconazole. Clinical studies have shown it to have more bioavailability than generic itraconazole. The Hedgehog signaling pathway is a significant regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, as well as cell proliferation.
The Company believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Leveraging research undertaken by key investigators in the field, HedgePath’s plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.
The design of “SUBA technology” (which stands for “Super Bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and substantially reduced variability in comparison to generic itraconazole.
In August of 2018, HedgePath Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) confirmed HedgePath’s present clinical and regulatory pathway related to the Company’s SUBA™-Itraconazole as a treatment for Basal Cell Carcinoma (BCC) in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS, or Gorlin Syndrome).
This past December, HedgePath Pharmaceuticals announce that it entered into a revised Supply and License Agreement (SLA) with its majority stockholder Mayne Pharma Ventures Pty Ltd (Mayne Pharma), an affiliate of Mayne Pharma Group Limited. With the new SLA, Mayne Pharma will assume control of the regulatory and clinical development program for SUBA®-Itraconazole for the treatment of basal cell carcinoma nevus syndrome (SUBA-Itraconazole BCCNS) in expectation of conducting a worldwide Phase 3 pivotal clinical trial based on results attained in the Phase 2(b) trial conducted by HedgePath in the United States. Mayne Pharma will immediately assume responsibility for all future SUBA-Itraconazole BCCNS-related expenses.
HedgePath Pharmaceuticals, Inc. (HPPI), closed Monday's trading session at $0.078, up 2.63%, on 50,200 volume with 4 trades. The average volume for the last 3 months is 14,491 and the stock's 52-week low/high is $0.04/$0.375.
Nemaska Lithium, Inc. (NMKEF)
Investing News, Streetwise Reports, Uptick News Wire, InvestorIntel, OTC Markets, Street Insider, Private Capital Journal, Metals News, Mining and Energy, Insider Financial, Stockhouse, Capital Equity Review, InvestorsHub, YCharts, and Junior Mining Network reported previously on Nemaska Lithium, Inc. (NMKEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
A developing chemical company, Nemaska Lithium, Inc.’s activities will be vertically integrated. This is from spodumene mining to the commercialization of high-purity lithium hydroxide and lithium carbonate. These lithium salts are chiefly for the lithium-ion battery market. Nemaska Lithium will be operating the Whabouchi mine in Quebec, Canada. The Whabouchi mine is one of the richest lithium spodumene deposits globally - in volume and grade. Nemaska Lithium is based in Quebec City, Quebec.
The spodumene concentrate produced at the Whabouchi mine will undergo processing at the Shawinigan plant employing an inventive membrane electrolysis process for which Nemaska Lithium holds several patents. The Company has received a notice of allowance of a main patent application on its proprietary process to produce lithium hydroxide and lithium carbonate. It is pursuing patent protection on this process in numerous worldwide jurisdictions.
The Whabouchi Property comprises one block totaling 33 claims covering an area of 1,761.9 ha. Nemaska Lithium 100 percent owns the claims. The Feasibility Study (FS) outlines a combined open pit and underground mine. The Company states that the Nemaska Whabouchi spodumene deposit in the Eeyou Istchee/James Bay Region of Quebec, near the Cree community of Nemaska, should have an initial lithium mine life of 26 years.
Recently, Nemaska Lithium announced that construction work at the Whabouchi mine will resume on Tuesday, February 5, 2019. Mine construction activities were put on hold on Thursday, January 31, 2019 following a fire in the cafeteria of the Nemiscau workcamp, a facility owned and operated by an outside contractor that is located about 15 km away from the Nemaska Lithium mine site.
Nemaska Lithium located an alternate cafeteria facility that is roughly 1 km from the existing lodging facility, which will be opened to accommodate Nemaksa Lithium’s employees until mid-March. This is when the Whabouchi mine site workcamp now under construction will be opened.
Nemaska Lithium, Inc. (NMKEF), closed Monday's trading session at $0.4652, down 2.33%, on 357,250 volume with 35 trades. The average volume for the last 3 months is 208,238 and the stock's 52-week low/high is $0.389/$1.47.
Sun Pacific Holding Corp. (SNPW)
MarketWatch, Marketwired, Zacks, 4-Traders, and Investorx reported previously on Sun Pacific Holding Corp. (SNPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sun Pacific Holding Corp., by way of its subsidiaries, provides solar bus stops, solar trashcans and “street kiosks” using its innovative advertising offerings that provide state and local municipalities with cost efficient solutions. The Company’s subsidiaries include Sun Pacific Power Corp., Street Smart Outdoor Corp., Sun Pacific Security Corp., and National Mechanical Group. A green energy, OTCQB-listed company, Sun Pacific is based in Manalapan, New Jersey.
Sun Pacific specializes in solar and waste to energy technologies. Subsidiary Sun Pacific Security will offer customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet. Sun Pacific Security has not commenced operations in the security sector. It is reviewing plans to provide customers the latest in security automation systems.
Subsidiary Sun Pacific Power builds next generation solar panels and lighting products made primarily in the United States. Sun Pacific Power has eight global manufacturing and assembly locations. These include five in the U.S.
Sun Pacific Power provides solar powered bus shelters, solar powered LED trash bins, solar products and lighting products. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security and other technological additions not previously available.
Street Smart Outdoor is Sun Pacific’s street furniture outdoor advertising subsidiary. Currently, it is maintaining advertising space on greater than 1,000 bus shelter faces, bus benches, smart solar digital shelters and solar trash bins.
Sun Pacific is integrating blockchain technology into its renewable energy business model and strategy designed to improve grid management efficiency for solar and wind farms. The Company earlier signed a Letter of Intent (LOI) to buy 60 acres of land to build a solar and wind farm, where electricity generation will be optimized via a combination of both energy sources. The Company plans to take the project one step closer to the future through using blockchain technology to monitor the new grid, load balance, and increase the life of electrical equipment.
Sun Pacific Holding Corp. (SNPW), closed Monday's trading session at $0.0042, down 10.64%, on 1,554,715 volume with 12 trades. The average volume for the last 3 months is 259,216 and the stock's 52-week low/high is $0.0042/$0.319.
Workhorse Group, Inc. (WKHS)
Stocktwits, MarketWatch, InvestorsHub, 4-Traders, Morningstar, GuruFocus, Simply Wall St, StreetInsider, Stockhouse, Equity Clock, Investing, Last10K, Zacks, Investopedia, The Street, Business Insider, and Capital Cube reported previously on Workhorse Group, Inc. (WKHS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Workhorse Group, Inc. is a technology company centered on providing sustainable and cost-effective electric mobility solutions to the commercial electric transportation sector. The Company designs and builds high performance battery-electric vehicles including trucks and aircraft. The design of all Workhorse vehicles is to make the movement of people and goods more efficient and less harmful to the environment. An American original equipment manufacturer (OEM), Workhorse Group is based in Loveland, Ohio.
The Company designs and produces battery-electric power trains in its 50,000 sq. ft. facility in Loveland for its new Workhorse chassis. Its approach to building its battery electric power trains uses proven, automotive-grade, mass-produced parts together with its custom designed, proprietary control software.
Workhorse Group also develops cloud-based, real-time telematics performance monitoring systems. These systems are totally integrated with its vehicles. They enable fleet operators to optimize energy and route efficiency. The Company is a top manufacturer of medium-duty electric step vans in America targeting commercial fleets. Workhorse Group is the only OEM building electrified medium-duty vehicles in America.
The Company is developing the Workhorse W-15, the U.S.’ first light-duty pickup truck with electric powertrain targeted at commercial fleets. Target customers include delivery fleets, utility companies, telecommunications companies, municipalities and more. Workhorse Group has its N-GEN Electric Delivery Van; the W-15 electric pickup truck with extended range; the E-Gen Step Van; the SureFly™ Helicopter; the HorseFly™ Autonomous Drone Delivery System; and the METRON™ Telematics and Asset Tracking Software.
The SureFly is classified as a personal helicopter/eVTOL aircraft. The Company has received FAA approval to test the copter. However, it is still trying to secure approval to sell it. Mr. Steve Burns, Workhorse Group Chief Executive Officer, said the Company is "six months into a two-year journey" to get the product approved and sold.
In addition, Workhorse Group is working with Duke Energy Corp. (NYSE: DUK) on a battery leasing program. This program would provide Duke Energy customers a cost-competitive product alternative.
As part of this relationship, signed on November 28, 2018, Duke Energy agreed to buy 615,000 Panasonic battery cells from Workhorse Group for $1.3 million. Duke’s plan is to explore further development of eFleet solutions to Workhorse customers that may include single-point management and financing of all the Behind the Meter (BTM) infrastructure required to support depot wide electrification, vehicle/battery leasing, as well as distributed energy resources.
Workhorse Group, Inc. (WKHS), closed Monday's trading session at $0.9997, up 3.06%, on 429,970 volume with 961 trades. The average volume for the last 3 months is 281,433 and the stock's 52-week low/high is $0.37/$3.31.
AltiGen Communications, Inc. (ATGN)
Stock Twits, Amigo Bulls, Wallet Investor, YCharts, Zacks, Marketwired, Investors Hangout, Stockhouse, InvestorsHub, OTC Markets, Simply Wall St, 4-Traders, MarketWatch, and Marketbeat reported previously on AltiGen Communications, Inc. (ATGN), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
AltiGen Communications, Inc. is a provider of Hosted Skype for Business and Contact Center solutions. The Company is a foremost Microsoft Cloud Solutions provider. It delivers fully managed Unified Communications services, uniting Hosted Skype for Business, Advanced Cloud PBX, as well as Innovative Cloud Contact Center applications with seamless integration to Office 365. AltiGen Communications has its corporate office in San Jose, California.
The design of the Company’s solutions is for high reliability, user-friendliness, and seamless integration to Microsoft infrastructure technologies. Its solutions are constructed on a scalable, open standards platform. AltiGen’s Cloud Unified Communications solution significantly simplifies deployment and management. This is while enabling SMBs and enterprises to considerably decrease costs and reduce total cost of ownership.
AltiGen Communications’ all-software solution provides businesses the flexibility to deploy on-premises, in the Cloud, or in a hybrid environment. AltiGen’s innovative and feature rich Cloud PBX and Multi-Channel Contact Center solutions natively integrate with Skype for Business and Office 365. This is to deliver business-critical functionalities required by SMBs (Small and Midsize Businesses) and enterprises.
AltiGen’s MaxUC is a unique new Unified Communications solution. It combines the Company’s MaxCS IP PBX with Microsoft’s Skype for Business. Furthermore, AltiGen has its MaxCS SIP Trunk. The SIP Trunk Service is an enterprise grade VoIP service optimized for AltiGen Communications solutions.
Additionally, The Company has its Enterprise Cloud PBX. This is a comprehensive Cloud-based enterprise-wide PBX and Contact Center solution for Office 365, based on AltiGen’s Hosted Skype for Business, integrated with its MaxACD advanced communications application set.
Moreover, AltiGen has the above-mentioned MaxACD Cloud. MaxACD enhances Skype for Business and Office 365 with Cloud-based Automated Multimedia Routing and Queuing capabilities to address the Enterprise “Line of Business” requirements for Internal or External customer requests.
Last month, Altigen Communications announced its financial results for Q1 ended December 31, 2018. Q1 Fiscal 2019 financial highlights include Revenue of $2.8 million. This represents a 20 percent increase over the year ago Q1. Net Income was $612,000 GAAP, $648,000 non-GAAP. In addition, Working Capital grew 20 percent to $2.8 million.
AltiGen Communications, Inc. (ATGN), closed Monday's trading session at $0.8699, down 1.84%, on 29,475 volume with 9 trades. The average volume for the last 3 months is 54,556 and the stock's 52-week low/high is $0.379/$0.949.
Canarc Resource Corp. (CRCUF)
ShazamStocks, CrushTheStreet, Baby Bulls, FeedBlitz, All Penny Stocks, Research Driven Investor, Future Money Trends, SmallCapVoice, and Stockhouse reported earlier on Canarc Resource Corp. (CRCUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Canarc Resource Corp. is a growth-oriented, gold exploration and mining company listed on the OTCQB. It is currently focusing on advanced Gold and Silver assets located in North America. Canarc Resource has its corporate headquarters in Vancouver, British Columbia.
The Company’s core Gold Project asset is the 100 percent owned, past-producing, high-grade New Polaris gold mine project in northwestern British Columbia. Based on an updated NI (National Instrument) 43-101 resource estimate using a 6 gpt gold cutoff grade, the New Polaris property presently contains measured and indicated resources of 519,000 oz gold contained in 1,288,000 tonnes grading 12.5 gpt gold.
New Polaris is the Company’s most advanced gold mine project. New Polaris contains inferred resources totaling 636,000 oz gold contained in 1,628,000 tonnes grading 12.2 gpt gold. It is still open for expansion in other veins and at depth.
Canarc Resource also has its Windfall Hills gold project. Windfall Hills is 65 kilometers south of Burns Lake and 90 kilometers northwest of Richfield Ventures’ Blackwater gold discovery in central British Columbia. The Windfall Hills project covers claims totaling 3879 hectares. The Company’s Projects also include Corral Canyon, Hard Cash and Nigel, and The Princeton Gold Property.
Last month, Canarc Resource announced the completion of a 970 line-km airborne magnetic and radiometric survey over the newly acquired 2,090 hectare Hard Cash Gold Property in southwestern Nunavut, Canada. Recently, Canarc Resource entered into an option agreement with Silver Range Resources to acquire a 100 percent interest in Hard Cash. Nunavut is home to two multi-million ounce gold deposits at the operating Meadowbank Mine and the Meliadine Mine now under construction, both owned by Agnico Eagle Mines.
Mr. Scott Eldridge, Canarc Resource Chief Executive Officer, stated: ''Since identifying Hard Cash late last year as a district scale gold exploration opportunity, Canarc has visited the site, sampled high grade gold in bedrock, signed an option agreement to acquire a 100% interest, completed an aero-geophysical survey, and we plan to drill the initial high priority targets this summer. We are moving expeditiously to execute our new corporate strategy of acquiring and exploring high impact gold discovery projects and de-risking our current core assets in order to create shareholder value.''
Canarc Resource Corp. (CRCUF), closed Monday's trading session at $0.04995, down 3.94%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 23,161 and the stock's 52-week low/high is $0.0239/$0.0658.
HCi Viocare (VICA)
MarketWatch and Financial Times reported previously on HCi Viocare (VICA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
HCi Viocare focuses on the development and marketing of prosthetics and orthotics. The Company has a strong pipeline of near-market to research-stage technologies. HCi Viocare has its executive office in Athens, Greece, and its research and development (R&D) center in Glasgow, Scotland, United Kingdom (UK). The Company’s shares trade on the OTC Markets’ OTCQB.
HCi Viocare has two fully owned subsidiaries. One is HCi Viocare Technologies. The other is HCi Viocare Clinics. HCi Viocare Technologies is developing hardware solutions aiming to empower the user through providing on demand information and enhancing living quality.
HCi Viocare’s business model consists of creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and developing an extensive portfolio of proprietary hardware solutions with first in line the Flexisense™ sensor system. The clinics will provide independent and personalized quality of care for its patients. The first HCi Viocare clinic has been operating since September 2015 in Glasgow.
The R&D center is working on a large portfolio of progressive, cutting-edge, and disruptive technologies in the Digital Health, Prosthetics, and Orthotics, Diabetes, Assistive Devices and Sports & Wellbeing fields. HCi Viocare has developed a unique sensing technology with the brand name Flexisense™.
Flexisense™ technology is the next generation of sensing technologies for wearable devices. Flexisense™ is an inventive sensing technology. It measures pressure and shear forces. In addition, it provides on demand information wirelessly. Flexisense can be incorporated in a wide array of applications.
The Company has developed a new application for its sensing technology Flexisense™, now for automotive tires. Flexisense™ applied to tires can monitor, in real time, tire deformation and actual traction between the tire and the ground.
HCi Viocare Management, acknowledging the great advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. This team will develop a proprietary Blockchain based system for handling and storing the data produced from the medical applications of its Flexisense™ technology.
In October of 2017, HCi Viocare welcomed Dr. John Doupis, MD, PhD to its team. Dr. Doupis joined the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center, Harvard Medical School, in Boston, Massachusetts, and Scientific partner in Beth Israel Deaconess Foot Center Harvard Medical School, Boston, Massachusetts. Dr. Doupis’ special areas of interest are Diabetes and its complications, particularly the Diabetic foot and Obesity.
HCi Viocare (VICA), closed Monday's trading session at $0.28, up 86.67%, on 300 volume with 2 trades. The average volume for the last 3 months is 418 and the stock's 52-week low/high is $0.15/$2.76.
Jerrick Media Holdings, Inc. (JMDA)
Penny Stock Tweets, CFN Media Group, Insider Tracking, Stockhouse and MassiveStockProfits reported earlier on Jerrick Media Holdings, Inc. (JMDA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Jerrick Media Holdings, Inc. is a digital media and technology company. It focuses on the development and marketing of branded digital content and e-commerce properties. The Company produces and distributes premier digital media across numerous platforms for many targeted demographics. Jerrick Media Holdings has its corporate headquarters in Fort Lee, New Jersey.
The Company’s brand portfolio is delivered through Vocal. This is its proprietary technology and content distribution platform. All verticals are supervised by the same team and ideology, concentrating chiefly on revenue conversion as the basis of all published material.
Vocal is a unique platform. It is a content distribution platform and publishing hub. The Vocal platform hosts manifold niche-communities. These include science fiction, poetry, music, health and wellness, and pop culture.
Vocal takes advantage of the power of specific and dedicated audiences with a developing content creation engine. It blends thought-provoking, appealing content with SEO (Search Engine Optimized) and monetization capabilities.
Jerrick Media is expanding its revenue opportunities (and those of its content creators) through leveraging the Jerrick library of assets by way of partnerships with celebrity thought-leaders and influencers.
Jerrick Media announced earlier this year that it entered into a Memorandum of Understanding (MOU) outlining the terms of a proposed joint venture (JV) with Thinkmill, Inc. With this MOU, Jerrick Media and Thinkmill will establish Abacus, a new Delaware entity.
Abacus will retain a non-exclusive license of the Vocal technology, users, and content from Jerrick Media for a five-year period. The mission of Abacus will be to develop strong solutions for content creators through further developing the Vocal platform and the established communities and content that presently exists.
Based on its current trajectory of greater than 1,000 new creators joining the Vocal platform on a daily basis, Jerrick Media anticipated that 300,000 content creators would be signed up to Vocal by the end of June 2018.
Jerrick Media Holdings, Inc. (JMDA), closed Monday's trading session at $0.12, up 20.00%, on 321,651 volume with 15 trades. The average volume for the last 3 months is 37,735 and the stock's 52-week low/high is $0.07/$0.379.
Tofutti Brands, Inc. (TOFB)
Zacks, Marketbeat, Penny Stock Hub, Stockopedia, Infront Analytics, Market Exclusive, and MarketWatch reported on Tofutti Brands, Inc. (TOFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Tofutti Brands, Inc. develops and distributes a complete line of dairy-free products. The Company’s products are available throughout the United States and in more than 30 countries. Tofutti Brands’ products serve the needs of millions of people who are allergic or intolerant to dairy, diabetic, kosher or vegan, as well as those who desire to have a healthier low-fat diet.
Formed in 1981, Tofutti Brands has its corporate office in Cranford, New Jersey. The Company’s shares trade on the OTC Markets Group’s OTCQB.
All Tofutti Brands products are certified Kosher Parve. This means that none of its products ever contain any dairy whatsoever. This means no milk by-products either, such as casein, whey, skim milk powder, or dairy lactic acid.
The Company sells greater than 40 milk-free foods. These include frozen desserts, cheese products and prepared frozen dishes. Tofutti Brands’ product line includes dairy-free ice cream pints, Tofutti Cutie® sandwiches, and Sour Supreme®, and Mintz's Blintzes®.
Concerning wholesale and/or food service, Premium Tofutti frozen dessert is available in 3-gallon containers. Tofutti Better Than Cream Cheese, Tofutti Better Than Ricotta Cheese, Tofutti Better Than Mozzarella Cheese, and Tofutti Better Than Sour Cream are available in an assortment of bulk sizes. These include 30 lb. blocks, 5 lb. containers, and 1 oz. portion-controlled cups (cream cheese only).
Additionally, Tofutti Brands has an increasing variety of prepared foods. These include Pizza Pizzaz® and the aforementioned Mintz's Blintzes® - all made with Tofutti Brands’ milk-free cheeses, including Better Than Cream Cheese® and Sour Supreme®. Tofutti dairy free cheeses, frozen desserts, and frozen foods can be found in major supermarkets and health food stores.
This past May, Tofutti Brands reported its results for the thirteen weeks ended March 31, 2018. Net Sales for the thirteen weeks ended March 31, 2018 grew by $491,000, or 15 percent, to $3,774,000, from Net Sales of $3,283,000 for the thirteen weeks ended April 1, 2017.
Tofutti Brands reported Net Income of $327,000 ($0.06 per share) versus a Net Loss of $173,000 ($0.03 per share) for the thirteen weeks ended April 1, 2017. Sales of vegan-cheese products grew to $3,132,000 in the 2018 period from $2,628,000 in the 2017 period. Sales of its vegan cheese product line increased because of an increase in its export and domestic cheese business.
Tofutti Brands, Inc. (TOFB), closed Monday's trading session at $1.91, up 3.24%, on 4,060 volume with 10 trades. The average volume for the last 3 months is 2,195 and the stock's 52-week low/high is $1.45/$3.17.
Cell Source, Inc. (CLCS)
InvestorsHub and OTC Markets reported on Cell Source, Inc. (CLCS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Cell Source, Inc. is a Biotechnology Company listed on the OTC Markets Group’s OTCQB. The Company concentrates on developing cell therapy treatments established on immunotherapy and regenerative medicine. Its principal product is the Veto-Cell immune system management technology. Cell Source has its headquarters in New York, New York.
Cell Source’s Veto-Cell immune system management technology is an immune tolerance biotechnology. It enables the selective blocking of immune responses. The Company’s Veto-Cell technology is utilized in varied applications. These include bone marrow transplantation, veto-cell in transplantation, anti-cancer, and also non-malignant diseases.
The patented Veto-Cell technology addresses one of the most fundamental challenges in human immunology. This challenge is: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats.
Veto cells disable the attack of the immune system on the bone marrow transplantation (BMT) only, without other side effects. The Veto cells act as “decoys” that attract, and then kill, the T-cell clones directed at the transplant.
The Veto cells continue “on guard” in the body for lengthy periods of time to further limit rejection. Therefore, the transplantation is accepted by the body without compromising the rest of the immune system.
The principal goal in developing Veto Cells is to have a meaningful and potentially widespread impact on the field of bone marrow and major organ transplantation. In addition, Veto Cells can be combined with other cell therapy treatments to improve their effectiveness. In preclinical studies, Veto Cells have been shown to increase efficacy and persistence of genetically modified cells.
Along with its Veto Cells technology, Cell Source has its Megadose Drug Combination technology. The method of action includes stem cells overcoming rejection by outnumbering immune rejecting cells, and drugs reduce the need for immune suppression.
The Company has a substantial Intellectual Property (IP) Portfolio, exclusively licensed to it from the Weizmann Institute of Science by way of Yeda Research and Development Company Ltd. covering Dr. Yair Reisner’s technologies.
Dr. Yair Reisner is former Chairman of the Department of Immunology of Israel’s Weizmann Institute of Science. He pioneered “mismatched” BMT (partial versus full donor/recipient match) with his patented “Megadose” cell therapy treatment.
In essence, Cell Source’s corporate mission is to transform the fields of transplantation, cancer treatment, and reversal of vital organ disease, using its pioneering immune tolerance and organ regeneration technologies.
Cell Source, Inc. (CLCS), closed Monday's trading session at $0.80, up 56.25%, on 100 volume with 1 trade. The average volume for the last 3 months is 2,078 and the stock's 52-week low/high is $0.2601/$1.09.
The Alkaline Water Company, Inc. (WTER)
StreetAuthority Financial, Dynamic Wealth Research, Investor Spec Sheet, Market FN, Wall Street Mover, Morningstar, SmallCapVoice, OTC Markets Group, Penny Stock Rumble, InvestmentHouse, Investors Insights, MicroCap Gems, Oakshire News Bulletin, and The Best Newsletters reported on The Alkaline Water Company, Inc. (WTER), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
The Alkaline Water Company, Inc. has developed a unique, state-of-the-art, proprietary electrolysis beverage process. This process produces healthy alkaline water. The water is packaged and sold in 500ml, 700ml, 1-liter, 3-liter and 1-gallon sizes under the trade name Alkaline88®. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes.
The Alkaline Water Company has its corporate office in Scottsdale, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB.
The Alkaline Water Company currently packages and sells its alkaline water to greater than 40,000 retail locations in all 50 states. The design of Alkaline88 is to encourage daily consumption of Alkaline Water by way of a consumer-oriented bulk delivery system aimed at removing expensive small bottles from the distribution supply chain. The production of Alkaline88 is at an 8.8 pH, intended to attain optimal body balance.
The Company incorporated 84 beneficial trace Himalayan minerals to make Alkaline88 especially unique to other pH waters. It utilizes an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals.
The ECA process uses specialized electronic cells coated with an array of rare earth minerals to produce scientifically engineered water. Alkaline88® is now available at select retailers in a 1.5-liter bottle and a 1-liter 6-pack.
Recently, The Alkaline Water Company announced record quarterly Sales were realized in its Q1 for the fiscal year ending March 31, 2019. The Company had record Q1 FY 2019 Sales of more than $7.85 million. Q1 FY 2019 Sales of more than $7.85 million were up over 51 percent versus Q1 FY 2018 Sales of $5.17 million.
The Alkaline Water Company also recently announced that its Phoenix, Arizona based co-packer, White Water, expanded its manufacturing facility that will substantially increase wholesale production capacity. At present, White Water occupies a 62,000 square foot facility, which operates six bottling lines with close to 50 employees. White Water is one of the largest privately-owned bottled water companies in the Southwest.
The Alkaline Water Company announced in late July that Heinen’s Inc., d/b/a Heinen’s Grocery Store (Cleveland, Ohio based) is now selling Alkaline88® water in its 1-gallon size at all of their retail locations throughout Ohio and Illinois.
The Alkaline Water Company, Inc. (WTER), closed Monday's trading session at $3.83, up 14.33%, on 2,815,307 volume with 8,323 trades. The average volume for the last 3 months is 325,711 and the stock's 52-week low/high is $0.80/$5.5625.
Gilla, Inc. (GLLA)
Greenbackers, SmallCapVoice, SmallCapFinancialWire, TopPennyStockMovers, Marketbeat, StockBlogs, and Real Pennies reported previously on Gilla, Inc. (GLLA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Gilla, Inc. manufactures, markets, and distributes E-liquid (the liquid used in vaporizers and E-cigarettes) and other vaping hardware and accessories. The Company’s aim is to be an international leader in delivering the most efficient and effective vaping solutions for nicotine and cannabis related products. Furthermore, Gilla is a developer of cannabis concentrate products.
The Company has its corporate office in Toronto, Ontario. Gilla’s manufacturing facility is in Daytona Beach, Florida.
Gilla's proprietary product portfolio includes Spectrum Concentrates, Coil Glaze™, Craft Vapes™, Siren, The Drip Factory, Shake It, Surf Sauce, Ohana, Moshi, Crisp, Just Fruit, Cassidy's Outlaw Series, Vinto Vape, Vapor's Dozen, Enriched Vapor, and Crown E-liquid™.
In May, Gilla announced its plan to pursue a spin-off of its cannabis-related business to Gilla's shareholders. The expectation is that the transaction will result in two separate public companies, which will benefit from separating their respective corporate strategies and capital allocation priorities.
Last month, Gilla announced that it entered into a Letter of Intent (LOI) to acquire all of the issued and outstanding shares of TB INVEST BVBA. TB INVEST is a Belgium-based distributor and retailer of E-liquid and other vapor products.
The acquisition of TB INVEST would be a transformative acquisition for Gilla creating a vertically integrated business amalgamating Gilla's worldwide manufacturing platform with TB INVEST's European-centered distribution and retail business.
TB INVEST was formed in Antwerp, Belgium in 2013. Its VaporShop retail brand is among the largest vape store retailers in Europe. VaporShop now has 47 franchised retail locations throughout Belgium in addition to TB INVEST's wholesale and retail distribution network of greater than 400 vendors throughout Europe.
Mr. Graham Simmonds, Chair and Chief Executive Officer of Gilla, said in July, "The acquisition of TB INVEST is a truly transformational opportunity for Gilla as consolidating our global manufacturing and distribution platform with TB INVEST's established wholesale and retail network will launch an exponential growth phase for Gilla. We look forward to utilizing the combined platform to grow our business in new geographies while further strengthening it in countries we already have a presence in."
Gilla, Inc. (GLLA), closed Monday's trading session at $0.0368, up 47.20%, on 16,877 volume with 3 trades. The average volume for the last 3 months is 47,020 and the stock's 52-week low/high is $0.022/$0.159.
Mikros Systems Corp. (MKRS)
Promotion Stock Secrets, PennyStockRumors, OTCEquity, PennyStocks24, AwesomeStocks, Wall Street Mover, PricelessPennyStocks, StockRockandRoll, Fast Money Alerts, Actual Gains, Marketbeat, AddictivePennyStocks, Chatter Box Stocks, StockLockandLoad, StockBomb, ResearchOTC, and OTPicks reported on Mikros Systems Corp. (MKRS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise, which designs and manufactures specialized electronic systems for the Department of Defense. Its chief business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. Mikros Systems is headquartered in Princeton, New Jersey. It has its Manufacturing and Depot Center in Largo, Florida.
Mikros’ capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering.
The Company produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.
Mikros Systems’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to achieve the highest levels of system readiness. The Company purchased certain software products, intellectual property (IP) and related assets from VSE Corp. The main software programs purchased by Mikros are the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs.
The Diagnostic Profiler software is used globally by many multinational companies for optimized maintenance of varied product lines. Also, Diagnostic Profiler is used by the U.S. Air Force for depot test programs.
Prognostics Framework is used by the U.S. Army for numerous missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.
Recently, Mikros announced it received a follow-on $2.5 million contract from the U.S. Navy to continue to develop its Condition-Based Maintenance (CBM) systems for the Navy's MK 99 Fire Control System (FCS). Mikros is developing a new variant of its ADSSS system.
This new contract award encompasses continued development, at-sea testing, and validation of the system. Under the contract, Mikros Systems’ CBM technology will be utilized for the first time in the Navy's Aegis surface combatant fleet of destroyers and cruisers.
The ADSSS system recently received official Navy nomenclature as the AN/SYM-3. It is presently used on the Navy's Littoral Combat Ship (LCS) to monitor two other radars and combat system elements. The new variant of the SYM-3, which will monitor the Director in the MK 99 system, has been in development since 2017.
Mikros Systems Corp. (MKRS), closed Monday's trading session at $0.3398, up 13.27%, on 4,900 volume with 5 trades. The average volume for the last 3 months is 13,925 and the stock's 52-week low/high is $0.259/$0.511.
The QualityStocks Company Corner
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Pressure BioSciences Inc. (PBIO)
- TransCanna Holdings Inc. (CSE: TCAN)
- Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)
- Cool Events Inc. (RNWR)
- Pacific Software, Inc. (PFSF)
- Canopy Rivers Inc. (TSX.V: RIV)
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
- Earth Science Tech, Inc. (ETST)
- Green Hygienics Holdings Inc. (GRYN)
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF)
- Marijuana Company of America Inc. (MCOA)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a publication from Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, which released a snapshot looking at the future of the retail cannabis market and companies competing for market share.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.54, up 3.18%, on 427,893 volume with 921 trades. The average volume for the last 3 months is 171,456 and the stock's 52-week low/high is $1.8068/$5.205.
- Going for the Gold in the Retail Cannabis Market
- Green Growth Brands Expands its Multi-State Operations into Arizona
- 420 with CNW – Cannabis College Starts Training Oklahomans to Work in Cannabis Dispensaries
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured in the Virtual Investor Conferences, the leading proprietary investor conference series. KCSA Strategic Communications has announced that the presentations from the January 30th Cannabis Virtual Conferences are now available for on-demand viewing at www.VirtualInvestorConferences.com.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.87, up 2.72%, on 1,720,981 volume with 2,321 trades. The average volume for the last 3 months is 982,908 and the stock's 52-week low/high is $1.607/$7.894.
- Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
- The Green Organic Dutchman Provides Construction Update and Increases Capacity
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) 5 Cannabis Stocks Under $5
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and related services for the global life sciences industry, today announced that its president and CEO, Richard T. Schumacher, was featured on the Uptick Newswire Stock Day Podcast with Everett Jolly. To listen to the full interview, visit http://nnw.fm/xiZ1j. To view the full press release, visit: http://nnw.fm/13gNZ.
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed the day's trading session at $2.67, up 16.09%, on 56,278 volume with 113 trades. The average volume for the last 3 months is 7,505 and the stock's 52-week low/high is $1.52/$5.00.
- NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Featured on Uptick Newswire
- NutraFuels, Inc. and Pressure BioSciences, Inc. to Collaborate on the Development of Water-Soluble Nanoemulsion-based Nutraceuticals
- Record Number of Scientific Papers Citing the Significant Benefits of Pressure BioSciences' PCT Platform Published in 2018
TransCanna Holdings Inc. (CSE: TCAN)
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that on February 1st the Company accepted an assignment of a real estate option agreement ("Option Agreement") from its CEO, Jim Pakulis, to acquire a land, building and asset package (the "Property") which includes an existing 196,000 square foot facility on 6.5 acres of land, as well as cannabis packaging and processing equipment. Also today, the company was featured in an article from The Cannabis Investor (or "TCI"), an investment newsletter focused on uncovering paradigm-shifting marijuana stocks, reports on the west coast roll-out of legal cannabis.
TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.
California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.
TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.
TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.
TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.
As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.
Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.
The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.
For additional information, call: (604) 609-6199
TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.54, up 7.17%, on 404,066 volume with 206 trades. The average stock's 52-week low/high is $0.77/$2.59.
- TransCanna Enters Into Option To Acquire 196,000 Square Foot, Fully Enclosed Cannabis Facility on 6.5 Acres of Land
- TransCanna Holdings - Meeting the Dire Needs of the Booming California Cannabis Industry
- TransCanna Signs LOI To Acquire Goodfellas Group, LLC
Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)
The world is rapidly becoming preoccupied with planetary climate changes as temperatures swing wildly, the Earth’s poles alter their icy constitutions, extreme weather events grow in intensity and sea coast areas experience flooded real estate (http://nnw.fm/Ji20z). Kontrol Energy (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) is attempting to lead out smart management efforts for utilities usage through a strong merger and acquisition philosophy as consumers become ever-more conscious of their impact on the situation.
Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.
Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.
As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.
Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.
Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.
Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:
- Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
- Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
- Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
- Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
- Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.
The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.
The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.
Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.
Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.61, up 1.67%, on 500 volume with 1 trade. The average volume for the last 3 months is 19,836 and the stock's 52-week low/high is $0.46/$1.44.
- Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Continues to Build M&A Assets in Drive to Boost Smart Energy Management
- NetworkNewsBreaks – Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Launches SmartMax(R) Energy Gateway into the Global Market
- Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) Helps Clients Realize Energy Saving Goals through an Array of Innovative Products and Services
Cool Events Inc. (RNWR)
Cool Events Inc. (OTC: RNWR) offers an array of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. The company produced over 120 events in 2018 under the banner of five successful brands and has already lined up venues for 2019.
Cool Events Inc. (RNWR) offers an array of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. The company produced over 120 events in 2018 under the banner of five successful brands and has already lined up venues for 2019.
Cool Events offers the following trademarked events throughout the nation, with each dedicated to raising funds for important charities: Blacklight Run, the largest glow powder run in the world; Bubble Run, the largest daytime 5K run in the country; Foam Glow, The largest nighttime glow run in the country and the world’s only glowing foam run; Blacklight Slide, the first and only close to five story high Glow-N-Dark water slide with neon glowing water; and Terrain Race, the nation’s fastest growing and industry leading obstacle course race for all ages and athletic abilities.
Cool Events dedicates each of its trademarked runs and events to childhood cancer awareness, making sure this critically important issue is spread throughout the nation one runner, one race at a time. Since its first event in August 2013, the company has donated more than $1 million to Phoenix Children’s Hospital/Children’s Miracle Network and hundreds of thousands more to other charity partners such as Ronald McDonald House Charities of New Mexico, Make-a-Wish Foundation, Adoption Awareness, Special Olympics Massachusetts, St. Jude Children’s Research Hospital, Kendra’s Kisses, Boys and Girls Club and many more over the years.
Cool Events brings a seasoned management team with 35 years of combined experience in operating experiential events including obstacle course races, running races, experiential family events and other competitive events. The Cool Events team also offers consulting, marketing and development for outside events. The company’s in-house marketing agency can handle all brand awareness for event strategy, bringing an event’s vision and goals to life.
Cool Events Inc. (RNWR), closed the day's trading session at $0.0555, up 0.91%, on 36,200 volume with 4 trades. The average volume for the last 3 months is 19,990 and the stock's 52-week low/high is $0.002/$0.231.
- Cool Events Inc. (RNWR) is “One to Watch”
- 808 Renewable Energy Corporation Completes Merger with Cool Events, LLC and Provides Shareholder Update
- Cool Technologies Announces Showcase of Mobile Production Generation System
Pacific Software, Inc. (PFSF)
Pacific Software (OTC: PFSF), an emerging business development technology innovator, revealed earlier this month that its anticipated e-commerce platform for international transactions, BOAPIN, will begin registering new buyers and sellers shortly as it shapes a virtual silk road for trade between China and South America. To view the full article, visit: http://nnw.fm/mYQi5.
Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.
The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.
Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.
With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.
Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.
Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.
As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.
Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The stock's 52-week low/high is $3.50/$5.50.
- NetworkNewsBreaks – Pacific Software Inc. (PFSF) Focuses on Building Virtual Silk Road Linking China and Brazil
- Pacific Software Inc. Partners with Prominent Brazilian Trade Association to Market its E-Commerce Trade Portal BOAPIN.com
- Pacific Software Inc. (PFSF) Prepares to Advance China-Brazil Trade through BOAPIN Launch
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSXV: RIV) is pleased to announce that it has completed a subsequent $9.4 million equity investment in its portfolio company Canapar Corp. (“Canapar Canada”), the Canadian parent corporation of Canapar SrL (“Canapar Italy”), an Italy-based organic hemp production and processing platform. The investment aligns with the Company’s global-focused growth strategy and is expected to provide the Company with the opportunity to capitalize on the rapidly expanding European cannabidiol (“CBD”) market. Also today, the company was highlighted in an article discussing how, controversial or not, you can't ignore the cannabis boom. In fact, analysts at Cowen say U.S. cannabis sales alone could reach $80 billion by 2030 - an increase of $5 billion from earlier estimates, and a 4% compound annual growth rate.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $5.22, off by 3.51%, on 1,126,325 volume with 2,112 trades. The average volume for the last 3 months is 446,738 and the stock's 52-week low/high is $2.40/$11.82.
- Canopy Rivers Announces Completion of $17 Million Financing for Its Italian Hemp Platform – Canapar
- Three of the Biggest Beneficiaries of the Cannabis Market Boom
- Canopy Rivers Corporation (TSX.V: RIV) (OTC: CNPOF) is “One to Watch”
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc (OTCQX: SPRWF) was highlighted as one of a handful of marijuana stocks gaining momentum as the market has continued to demonstrate its strength despite the fact that, at times, conversation surrounding cannabis can become less than beneficial. Also today, CannabisNewsWire released a report featuring the company which examines the recent news that legislators in Minnesota have introduced a bill that is intended to legalize recreational marijuana for adults in the state.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.6279, off by 5.35%, on 1,131,193 volume with 1,473 trades. The average volume for the last 3 months is 389,305 and the stock's 52-week low/high is $0.85/$2.04.
- These 4 Marijuana Stocks are Gaining Speed
- 420 with CNW – Minnesota Legislators Introduce Marijuana Legalization Bill
- NetworkNewsBreaks – The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) to Commence Trading on the Toronto Stock Exchange
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) was highlighted today in a report published by Investorideas.com, as a special edition of The AI Eye hit the wires, which looks at how this technology is disrupting multiple industry verticals and shifting them into a new era of efficiency.
Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.
The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.
“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”
Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.
LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.
Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.
The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.
Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.
World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.
Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.
Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.
The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.
Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.
Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $0.9705, off by 4.85%, on 168,951 volume with 108 trades. The average volume for the last 3 months is 41,705 and the stock's 52-week low/high is $0.59/$1.95.
- AI’s Rising Tide Lifts Industry Verticals
- Advanced Technology for Rapid Extraction Will Be Key to Meeting Future Lithium Demand
- Standard Lithium Announces Maiden Inferred Resource Of 802,000 Tonnes LCE At South-Western Arkansas Tetra Project
Earth Science Tech, Inc. (ETST)
Earth Science Tech (OTCQB: ETST), a Florida-based biotechnology company focused on cannabis and cannabinoid research and development, nutraceuticals, pharmaceuticals and medical devices, sees new opportunity in the passing of the 2018 Farm Bill. To view the full article, visit: http://nnw.fm/j1Ee5.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.9705, off by 4.85%, on 44,000 volume with 46 trades. The average volume for the last 3 months is 32,631 and the stock's 52-week low/high is $0.59/$1.95.
- NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Capitalizing on Hemp Legalization with Recent Changes in Staff Driving CBD Product Distribution
- Earth Science Tech, Inc. (ETST) to Introduce Super Supplement to Boost Brain Power
- Earth Science Tech, Inc. (ETST) to Exhibit Hygee™ at the Arab Health Medical Trade Fair in Dubai
Green Hygienics Holdings Inc. (GRYN)
The demand for cannabis-related real estate has increased significantly in San Diego after the recent legalization and approval of three additional industrial properties for planned marijuana production (http://nnw.fm/LkRj9). While this increases the challenge for many marijuana growers, it could give an advantage to companies such as Green Hygienics Holdings Inc. (OTC: GRYN), whose aeroponics growing system requires limited land and resources, as compared to traditional growing techniques.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.
The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.
Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.
Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.
Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.
The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.
Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.
Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.48, off by 5.88%, on 6,620 volume with 7 trades. The average volume for the last 3 months is 14,160 and the stock's 52-week low/high is $0.033/$0.548.
- Positive Legislative Changes to Facilitate Green Hygienics Holdings Inc.’s (GRYN) Growth in San Diego
- 420 with CNW – Cannabis College Starts Training Oklahomans to Work in Cannabis Dispensaries
- 420 with CNW – Arkansas Delays Issuing Medical Cannabis Cards
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)
FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that further to its news releases of January 11 and January 30, 2019 wherein it announced the closing of its oversubscribed Secured Convertible Debentures (“Debentures”) financing in the amount of $2.4 million with firm commitments for an additional $1.875 million, today advises that it has increased the size of its second tranche financing to $2.1 million for an aggregate total of $4.5 million. This is the final increase to the financing that is scheduled to close on or before February 8, 2019, as previously announced.
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.
Medical Cannabis Market
According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.
Royalty Model & Portfolio
FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.
FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.
CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.
The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.
Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.
FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.
The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.
FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.1298, off by 4.11%, on 63,850 volume with 26 trades. The average volume for the last 3 months is 41,624 and the stock's 52-week low/high is $0.0577/$0.68.
- FinCanna Announces Final Upsize to Convertible Debenture Financing to total $4.5 Million
- FinCanna Signs Royalty Agreement with Multi Brand Manufacturer, QVI, of Sonoma County, California
- FinCanna Upsizes Convertible Debenture Financing to total $4.275 Million
Marijuana Company of America Inc. (MCOA)
Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) recently reported that it is developing a new strategy to internationally expand its hempSMART brand. To view the full article, visit: http://nnw.fm/QQm0p.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0163, off by 3.55%, on 6,562,652 volume with 371 trades. The average volume for the last 3 months is 13,956,611 and the stock's 52-week low/high is $0.0115/$0.0499.
- NetworkNewsBreaks — Marijuana Company of America Inc. (MCOA) Plans to Expand hempSMART Brand into Europe and Asia
- Marijuana Company of America Inc. (MCOA) Engages in the Cultivation and Distribution of Hemp-Derived Products
- Marijuana Company of America Announces Successful Prelaunch of Hempsmart in the United Kingdom
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Leading the Way as Novel Therapies Fuel Growth of Breast Cancer Treatment Market
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Advances Personalized Immunotherapy Technology Targeting Advanced Breast Cancer Patients
- Cannabis Strategic Ventures, Inc. (NUGS) Hemp Proving to have Major Growth Potential Across Many Industries and Products
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Completion of $17 Million Financing for Its Italian Hemp Platform – Canapar
- ChineseInvestors.com (CIIX) 2/1, MoneyTV with Donald Baillargeon
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) ParcelPal CEO Kelly Abbott Provides a Corporate Update
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) is “One to Watch”
- Cyberfort Software, Inc. (CYBF) Uptick Newswire Stock Day Podcast Hosts Cyberfort Software Inc. to Discuss Future Plans and The Announcement of Their Acquisition of Just Content Software
- Earth Science Tech, Inc. (ETST) Capitalizing on Hemp Legalization with Recent Changes in Staff Driving CBD Product Distribution
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Announces Final Upsize to Convertible Debenture Financing to total $4.5 Million
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Provides Update on Refinery Material Testing Progress
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Provides Update on Refinery Material Testing Progress
- Generation Alpha, Inc. (GNAL) 420 with CNW – Legalization Changes How Canadians Talk to Kids about Cannabis
- Global Payout, Inc. (GOHE) MTrac System Sweeps The Nation With Proof of Concept, Showcases Revenue And Rapid Expansion
- Golden Developing Solutions, Inc. (DVLP) Recent WheresCBD.com Launch Expands Hemp-related Products Strategy
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Going for the Gold in the Retail Cannabis Market
- Green Hygienics Holdings Inc. (GRYN) Positive Legislative Changes to Facilitate Green Hygienics Holdings Inc.’s (GRYN) Growth in San Diego
- Icon Exploration Inc. (TSX.V: IEX.H) Aims to Capitalize on the Medical and Recreational Cannabis Markets
- Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Continues to Build M&A Assets in Drive to Boost Smart Energy Management
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Gaining Appeal in Cannabis Edibles with DehydraTECH
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Plans Second Program for Additional T.E.M and Follow Up Drilling on The Turi Prospect
- Marijuana Company of America Inc. (MCOA) Plans to Expand hempSMART Brand into Europe and Asia
- Medical Cannabis Payment Solutions (REFG) 420 with CNW – Craft Medical Cannabis Growers Form Co-op in British Columbia
- Net Element, Inc. (NASDAQ: NETE) Leading the Way in Transaction-Based Technological Innovation
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) NetworkNewsAudio Announces Audio Press Release (APR) on Pacific Rim Cobalt Corp. Well Positioned in Hunt for Cobalt
- Pacific Software, Inc. (PFSF) Focuses on Building Virtual Silk Road Linking China and Brazil
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) Provides Corporate Update Reviewing Completed Milestones, Strategic Initiatives
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Extends Lead in California Edibles Market with 3 of Top 5 Cannabis Products in Q4
- Pressure BioSciences Inc. (PBIO) CEO Featured on Uptick Newswire
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Preparing Test Production of Saleable Lithium Material
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) 420 with CNW – Why Suppositories will be Big in the Medical Marijuana Industry
- Sharing Services, Inc. (SHRV) Revolutionizing the Entrepreneurial Industry
- SinglePoint, Inc. (SING) CEO Reiterates Bullish Position on CBD in Episode of MoneyTV with Donald Baillargeon
- Spectrum Global Solutions, Inc. (SGSI) Announces Uplisting to OTCQB Venture Market
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Financial Results for the Third Quarter of 2018
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) AI’s Rising Tide Lifts Industry Verticals
- Sugarmade, Inc. (SGMD) to Acquire Hydroponic Retailer Hydro4Less Flagship Location Adding to Streak of Planned Acquisitions
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) Uptick Newswire Hosts Sunniva Inc.’s Co-Founder to Discuss the Infrastructure Now in Place That Has Let Them Enter The World’s Largest Cannabis Market
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) These 4 Marijuana Stocks are Gaining Speed
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) to Launch Cannabis Clone and Seed Sales in Second Quarter
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – The Most Expensive Cannabis Product is Sold in Las Vegas
- TransCanna Holdings Inc. (CSE: TCAN) Enters Into Option To Acquire 196,000 Square Foot, Fully Enclosed Cannabis Facility on 6.5 Acres of Land
- United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) Retracts Technical Disclosures
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Missouri Prosecutors Change Stance on Marijuana Cases
- Youngevity International, Inc. (NASDAQ: YGYI) CannabisNewsAudio Announces Audio Press Release (APR) on Youngevity International Primed to Take Advantage of Opportunity in CBD Market
- Zenergy Brands, Inc. (ZNGY) Announces Joint-Marketing Agreement with National Consultancy — Energy Professionals
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.